8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28447000)

Published in Ann Cardiothorac Surg on March 01, 2017

Authors

Thomas W Rice1, Deepa T Patil2, Eugene H Blackstone1,3

Author Affiliations

1: Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
2: Department of Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
3: Department of Quantitative Health Sciences, Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Articles cited by this

Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer (1994) 6.31

Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology (1997) 4.10

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology (2005) 2.02

Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01

Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy (1995) 1.87

A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut (2001) 1.72

Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2015) 1.71

Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69

Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc (2009) 1.68

Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol (2007) 1.56

Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol (2008) 1.52

Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg (1999) 1.42

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40

T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg (2007) 1.38

Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer (2002) 1.28

Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg (2001) 1.04

Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma. Am J Surg Pathol (2008) 1.00

Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy (2007) 0.99

Diagnosis and staging of cancer of the esophagus and esophagogastric junction. Surg Clin North Am (2012) 0.96

Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg (2014) 0.95

Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2006) 0.92

Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg (2007) 0.90

Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res (2005) 0.89

Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. Am J Clin Pathol (2008) 0.88

Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer (2016) 0.87

Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus (2016) 0.85

The endoscopic diagnosis and staging of oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol (2006) 0.85

Treatment of clinical T2N0M0 esophageal cancer. Ann Surg Oncol (2014) 0.83

Prospective comparison of endosonography, computed tomography, and histopathological stage of junctional oesophagogastric cancer. Clin Radiol (2008) 0.83

Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer. Dis Esophagus (2010) 0.83

High-frequency endoscopic ultrasonography in the evaluation of superficial esophageal cancer. Endoscopy (2003) 0.82

Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma. Am J Surg Pathol (2006) 0.82

Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus (2016) 0.82

Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus (2016) 0.81

Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus (2016) 0.80

Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters. Abdom Imaging (2009) 0.79

Possibility of pre-operative diagnosis of lymph node metastasis based on morphology. Hepatogastroenterology (1999) 0.79

Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer. Surg Endosc (2016) 0.79

Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg (2017) 0.78

Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. Ann Thorac Surg (2015) 0.77

Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus (2016) 0.77

Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg (2017) 0.77

Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus (2016) 0.76

Endoscopic Submucosal Dissection for Barrett's Early Neoplasia: A Multicenter Study in the United States. Gastrointest Endosc (2016) 0.76